Bank Of New York Mellon Corp Kempharm, Inc Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.12 - $5.62 $472,259 - $644,198	114,626 New	114,626 $526,000
Q2 2022 Aug 15, 2022	SELL	$4.02 - $5.21 $182,713 - $236,799	-45,451 Reduced 27.78%	118,166 $527,000
Q1 2022 May 11, 2022	BUY	$5.0 - $9.26 $381,365 - $706,287	76,273 Added 87.32%	163,617 $823,000
Q4 2021 Feb 11, 2022	BUY	$7.6 - $10.26 $14,364 - $19,391	1,890 Added 2.21%	87,344 $761,000
Q3 2021 Nov 12, 2021	BUY	$8.72 - $13.31 $111,694 - $170,487	12,809 Added 17.63%	85,454 $797,000
Q2 2021 Aug 11, 2021	BUY	$8.52 - $15.47 $618,935 - $1.12 Million	72,645 New	72,645 $931,000

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.